Publications
BDI along with colleagues in the field of diabetes health and mental well being are continuously working on research projects to further improve the lives of people living with diabetes worldwide.
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System
Authors: William H Polonsky, Korey K Hood, Carol J Levy, Sarah A MacLeish, Irl B Hirsch, Sue A Brown, Bruce W Bode, Anders L Carlson, Viral N Shah, Ruth S Weinstock, Anuj Bhargava, Thomas C Jones, Grazia Aleppo, Sanjeev N Mehta, Lori M Laffel, Gregory P Forlenza, Jennifer L Sherr, Lauren M Huyett, Todd E Vienneau, Trang T Ly, Omnipod
A new perspective on diabetes distress using the type 2 diabetes distress assessment system (T2-DDAS): Prevalence and change over time
Authors: L Fisher, W H Polonsky, M Perez-Nieves, U Desai, L Strycker, D Hessler Abstract Aims: To establish cut-points and thresholds for elevated diabetes distress; document change over time; and define minimal clinically important differences (MCID) using the new Type 2 Diabetes Distress Assessment System (T2-DDAS). Methods: A national sample of adults with type 2 diabetes completed the T2-DDAS CORE
The Influence of Real-Time Continuous Glucose Monitoring on Psychosocial Outcomes in Insulin-Using Type 2 Diabetes
Authors: Emily C Soriano, William H Polonsky Abstract Background: To examine the impact of real-time continuous glucose monitoring (rtCGM) on psychosocial outcomes in adults with insulin-using type 2 diabetes (T2D). Methods: A total of 174 insulin-using adults with T2D completed questionnaires assessing diabetes distress, hypoglycemic confidence, hypoglycemic fear, device-related emotional burden, and device-related trust before and after a six-month trial
The Role of Retrospective Data Review in the Personal Use of Real-Time Continuous Glucose Monitoring: Perceived Impact on Quality of Life and Health Outcomes
Authors: William H Polonsky, Emily C Soriano, Addie L Fortmann Abstract Background: To explore whether regularly reviewing one’s own retrospective continuous glucose monitoring (CGM) data might be linked with perceived quality of life (QoL) and glycemic benefits. Methods: Adults with type 1 diabetes (N = 300) or insulin-using type 2 diabetes (N = 198) using the Dexcom G5 Mobile or
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
Authors: David C Klonoff, Jing Wang, David Rodbard, Michael A Kohn, Chengdong Li, Dorian Liepmann, David Kerr, David Ahn, Anne L Peters, Guillermo E Umpierrez, Jane Jeffrie Seley, Nicole Y Xu, Kevin T Nguyen, Gregg Simonson, Michael S D Agus, Mohammed E Al-Sofiani, Gustavo Armaiz-Pena, Timothy S Bailey, Ananda Basu, Tadej Battelino, Sewagegn Yeshiwas Bekele, Pierre-Yves Benhamou, B Wayne Bequette,
A systematic review and meta-analysis to compare the prevalence of depression between people with and without Type 1 and Type 2 diabetes
Authors: Aaisha Farooqi, Clare Gillies, Harini Sathanapally, Sophia Abner, Sam Seidu, Melanie J Davies, William H Polonsky, Kamlesh Khunti Abstract Aims: Diabetes can significantly impact quality of life and mental health. However, inconsistencies have been reported in the prevalence of depression in those with Type 1 and Type 2 diabetes, and those without. Systematic reviews also included studies without adequate
Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review
Authors: Marc Evans, Susanne Engberg, Mads Faurby, João Diogo Da Rocha Fernandes, Pollyanna Hudson, William Polonsky Abstract We designed a systematic literature review to identify available evidence on adherence to and persistence with antidiabetic medication in people with type 2 diabetes (T2D). Electronic screening and congress searches identified real-world noninterventional studies (published between 2010 and October 2020) reporting estimates of
Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 Diabetes
Authors: Stephanie Edwards, Xuanyao He, Wenjie Wang, Jiat-Ling Poon, Eric Meadows, David Price, Jennal Johnson, Howard Wolpert, William Polonsky Abstract Objective: This study used connected pen to determine missed bolus dose (MBD) frequency during masked and unmasked continuous glucose monitoring (CGM) periods and examined its link with time-in-range (TIR), time-above-range (TAR), time-below-range (TBR), and key participant characteristics in people with
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Authors: Grazia Aleppo, Roy W. Beck, Ryan Bailey, Katrina J. Ruedy, Peter Calhoun, Anne L. Peters, Rodica Pop-Busui, Athena Philis-Tsimikas, Shichun Bao, Guillermo Umpierrez, Georgia Davis, Davida Kruger, Anuj Bhargava, Laura Young, John B. Buse, Janet B. McGill, Thomas Martens, Quang T. Nguyen, Ian Orozco, William Biggs, K. Jean Lucas, William H. Polonsky, David Price, Richard M. Bergenstal, MOBILE Study
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial
Authors: Thomas Martens, Roy W Beck, Ryan Bailey, Katrina J Ruedy, Peter Calhoun, Anne L Peters, Rodica Pop-Busui, Athena Philis-Tsimikas, Shichun Bao, Guillermo Umpierrez, Georgia Davis, Davida Kruger, Anuj Bhargava, Laura Young, Janet B McGill, Grazia Aleppo, Quang T Nguyen, Ian Orozco, William Biggs, K Jean Lucas, William H Polonsky, John B Buse, David Price, Richard M Bergenstal, MOBILE Study
I'm looking for information about...
For People with Diabetes
For Healthcare Professionals
Community Resources
Scales & Measures
Diabetes Distress Assessment
BDI Monthly Events
Publications
BDI along with colleagues in the field of diabetes health and mental well being are continuously working on research projects